Screening for decreased renal function in taxi drivers in Tehran, Iran

Renal Failure

Volumn 32, Issue 1, 2010, Pages 62-68

  Mahdavi Mazdeh, Mitra ^a   Saeed Hashemi Nazri, Seyed ^b   Hajghasemi, Ebrahim ^c   Nozari, Behnaz ^a   Zinat Nadia, Hatmi ^b   Mahdavi, Azita ^d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Applied Science Center of Tehran Municipality   (Iran)

^d National BEHZISTI Organization   (Iran)

Author keywords

Chronic kidney disease; Glomerular filtration rate; Iran; Renal function; Screening

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BLOOD CELL COUNT; BLOOD PRESSURE; BODY MASS; CAR DRIVER; CHRONIC KIDNEY DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEMOGRAPHY; DISEASE COURSE; EDUCATIONAL STATUS; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; IRAN; KIDNEY FAILURE; KIDNEY FUNCTION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; SCREENING; URINALYSIS;

EID: 76449097758     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/08860220903491190     Document Type: Article

References (43)

1. Bennett L. Changing European CKD trends: A call to action. J Ren Care. 2007 Oct-Dec;33(4):148-152.
2. Hamer R, El-Nahas AM The burden of chronic kidney disease. BMJ. 2006;332:563-564.
3. Schieppati A, Remuzzi G. Chronic renal diseases as a public health problem: Epidemiology, social, and economic implications. Kidney Int Suppl. 2005 Sep; 98:S7-S10. (Pubitemid 43307841)
4. Reynolds K, Gu D, Muntner P, Kusek JW, Chen J, Wu X, et al. A population-based, prospective study of blood pressure and risk for end-stage renal disease in China. J Am Soc Nephrol. 2007 Jun;18(6):1928-1935.
5. Barsoum RS. Chronic kidney disease in the developing world. N Engl J Med. 2006;354:997-999.
6. Mahdavi-Mazdeh M, Zamani M, Zamyadi M, Rajolani H, Tajbakhsh K, Heidary Rouchi A, et al. Hemodialysis cost in Tehran, Iran. Hemodialysis International. 2008;12(4):492-498.
7. Hallan SI, Vikse BE. Relationship between chronic kidney disease prevalence and end-stage renal disease risk. Curr Opin Nephrol Hypertens. 2008 May;17(3):286-291.
8. Collins AJ, Li S, Gilbertson DT, Liu J, Chen SC, Herzog CA. Chronic kidney disease and cardiovascular disease in the Medicare population. Kidney Int Suppl. 2003 Nov;87: S24-S31.
9. Annear NMP, Banerjee D, Joseph J, Harries TH, Rahman S, Eastwood JB. Prevalence of chronic kidney disease stages 3- 5 among acute medical admissions: Another opportunity for screening. QJM. 2008;101(2):91-97.
10. Levey AS, Andreoli SP, DuBose T, Provenzano R, Collins AJ. Chronic kidney disease: Common, harmful, and treatable- World Kidney Day 2007. J Am Soc Nephrol. 2007 Feb; 18(2): 374-378. (Pubitemid 46193301)
11. Correa-Rotter R, Cusumano AM. Present, prevention, and management of chronic kidney disease in Latin America. Blood Purif. 2008;26(1):90-94.
12. Cusumano AM, Gonzalez Bedat MC. Chronic kidney disease in Latin America: Time to improve screening and detection. Clin J Am Soc Nephrol. 2008 Mar; 3(2):594-600.
13. Iseki K. Chronic kidney disease in Japan. Intern Med. 2008;47(8):681-689.
14. Imai E, Yamagata K, Iseki K, Iso H, Horio M, Mkino H, Hishida A, Matsuo S. Kidney disease screening program in Japan: History, outcome, and perspectives. Clin J Am Soc Nephrol. 2007;2(6):1360-1366.
15. Wakai K, Nakai S, Kikuchi K, Iseki K, Miwa N, Masakane I, Wada A, Shinzato T, Nagura Y, Akiba T. Trends in incidence of end-stage renal disease in Japan, 1983-2000: Age-adjusted and age-specific rates by gender and cause. Nephrol Dial Transplant. 2004;19:2044-2052.
16. Stewart JH, McCredie MR, Williams SM, Jager KJ, Trpeski L, McDonald SP. ESRD Incidence Study Group: Trends in incidence of treated end-stage renal disease, overall and by primary renal disease, in persons aged 20-64 years in Europe, Canada and the Asia-Pacific region, 1998-2002. Nephrology. 2007;12:520-527.
17. Mahdavi-Mazdeh M, Heidary RA, Norouzi S, Aghighi M, Rajolani H, Ahrabi S. Renal replacement therapy in Iran. Urol J. 2007 Spring;4(2):66-70.
18. Mahdavi-Mazdeh M, Zamyadi M, Nafar M. Assessment of management and treatment responses in hemodialysis patients from Tehran province, Iran. Nephrology Dialysis Transplant. 2008;23(1):288-293.
19. Foundation NK. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1-S266.
20. Einollahi B, Nafar M, Bakhtiari S, Hajarizadeh B, Aghighi M. Epidemiology of CKD in Tehran Province. Kowsar. 2003;2(8):139-143.
21. Ito J, Dung DT, Vuong MT, Tuyen do G, Vinh le D, Huong NT, et al. Impact and perspective on chronic kidney disease in an Asian developing country: A large-scale survey in North Vietnam. Nephron Clin Pract. 2008;109(1):C25-C32.
22. Froissart M, Rossert J, Jacquot C, Paillard M, Houillier P. Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function. J Am Soc Nephrol. 2005;16(3):763-773.
23. Coresh J, Astor BC, McQuillan G, Kusek J, Greene T, Van Lente F, et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis. 2002; 39(5):920-929.
24. Pierre D, Eric PC. Formula-based estimates of the GFR: Equations variable and uncertain. Nephron. 2008;110(1):c48.
25. Nag S, Bilous R, Jones S, Kelly W, Connolly V. Comparison of the Cockcroft-Gault and modification of Diet in Renal Disease (MDRD) equations to determine the prevalence of chronic kidney disease by estimated glomerular filtration rate in a population based cohort of diabetic subjects: P73. Diabetic Medicine. 2006;23(Suppl. 2):49.
26. Zhang Q-L, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: Systematic review. BMC Public Health. 2008;8:117.
27. Aizawa M, Hayashi K, Shimaoka T, Yamaji K, Horikoshi S, Tomino Y. [Comparison of prediction equations of glomerular filtration rate in Japanese adults]. Nippon Jinzo Gakkai Shi. 2006;48(2):62-66 [in Japanese].
28. Mahajan S, Mukhiya GK, Singh R, Tiwari SC, Kalra V, Bhowmik DM, et al. Assessing glomerular filtration rate in healthy Indian adults: A comparison of various prediction equations. J Nephrol. 2005 May-Jun;18(3):257-261.
29. Giles PD, Fitzmaurice DA. Formula estimation of glomerular filtration rate: Have we gone wrong? BMJ. 2007;334: 1198-1200.
30. Hallan S, Asberg A, Lindberg M, Johnsen H. Validation of the modification of diet in renal disease formula for estimating GFR with special emphasis on calibration of the serum creatinine assay. Am J Kidney Dis. 2004 Jul;44(1):84-93.
31. Hansberry MR, Whittier WL, Krause MW. The elderly patient with chronic kidney disease. Adv Chronic Kidney Dis. 2005 Jan;12(1):71-77.
32. Carter JL, O'Riordan SE, Eaglestone GL, Delaney MP, Lamb EJ. Chronic kidney disease prevalence in a UK residential care home population. Nephrol Dial Transplant. 2008;23(4):1257-1264.
33. Zhang L, Zuo L, Xu G, Wang F, Wang M, Wang S, et al. Community-based screening for chronic kidney disease among populations older than 40 years in Beijing. Nephrol Dial Transplant. 2007;(22):1093-1099.
34. Garg AX, Papaioannou A, Ferko N, Campbell G, Clarke J-A, Ray JG. Estimating the prevalence of renal insufficiency in seniors requiring long-term care. Kidney Int. 2004; 66(5):2089.
35. Barbour SJ, Er L, Djurdjev O, Karim MA, Levin A. The prevalence of hematologic and metabolic abnormalities during chronic kidney disease stages in different ethnic groups. Kidney Int. 2008;74(1):108.
36. Richards N, Harris K, Whitfield M, O'Donoghue D, Lewis R, Mansell M, et al. The impact of population-based identification of chronic kidney disease using estimated glomerular filtration rate (eGFR) reporting. Nephrol Dial Transplant. 2008;23(2):556-561. (Pubitemid 351767654)
37. Zhang LX, Zuo L, Xu GB, Wang F, Wang M, Wang SY, Lv JC, Liu LS, Wang HY. Community-based screening for chronic kidney disease among populations older than 40 years in Beijing. Nephrol Dial Transplant. 2007;22:1093-1099.
38. Makaraite A, Bumblyte IA, Kuzminskis V, Valius L, Gofmanaite R, Bagdonaviciute G. [The prevalence of major risk factors for chronic kidney disease among patients in primary health care centers]. Medicina (Kaunas). 2007;43 (Suppl 1): 40-45.
39. Ryan TP, Sloand JA, Winters PC, Corsetti JP, Fisher SG. Chronic kidney disease prevalence and rate of diagnosis. Am J Med. 2007 Nov;120(11):981-986.
40. Cusumano A, Garcia-Garcia G, Di Gioia C, Hermida O, Lavorato C, Carreno CA, et al. End-stage renal disease and its treatment in Latin America in the twenty-first century. Ren Fail. 2006;28(8):631-637.
41. Hooi LS, Wong HS, Morad Z. Prevention of renal failure: The Malaysian experience. Kidney Int Suppl. 2005 Apr; 94:S70-S74.
42. Mani MK. Experience with a program for prevention of chronic renal failure in India. Kidney Int Suppl. 2005 Apr; 94:S75-S78.
43. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298(17):2038-2047. (Pubitemid 350074801)